Chemed Co. (NYSE:CHE) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA reduced its stake in Chemed Co. (NYSE:CHEFree Report) by 46.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,859 shares of the company’s stock after selling 92,827 shares during the period. Massachusetts Financial Services Co. MA owned approximately 0.72% of Chemed worth $57,144,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CHE. Trexquant Investment LP acquired a new stake in Chemed in the 4th quarter valued at about $6,172,000. Headlands Technologies LLC purchased a new stake in shares of Chemed during the fourth quarter worth approximately $230,000. Geode Capital Management LLC raised its holdings in Chemed by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 340,409 shares of the company’s stock valued at $180,654,000 after acquiring an additional 4,966 shares in the last quarter. Franklin Resources Inc. lifted its stake in Chemed by 18.6% in the fourth quarter. Franklin Resources Inc. now owns 10,436 shares of the company’s stock worth $5,529,000 after acquiring an additional 1,636 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. AG grew its holdings in Chemed by 8.7% during the 4th quarter. B. Metzler seel. Sohn & Co. AG now owns 560 shares of the company’s stock worth $297,000 after acquiring an additional 45 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Trading Down 3.4 %

CHE stock opened at $598.17 on Friday. The stock has a market cap of $8.76 billion, a P/E ratio of 30.23, a PEG ratio of 2.15 and a beta of 0.49. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $632.22. The company’s 50 day moving average is $580.24 and its two-hundred day moving average is $568.04.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed’s dividend payout ratio is currently 10.05%.

Analyst Ratings Changes

Several research firms have recently issued reports on CHE. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Royal Bank of Canada lifted their price target on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Read Our Latest Research Report on Chemed

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 3.32% of the stock is owned by corporate insiders.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.